Publications

Analysis of genetic variants of phosphodiesterase 11A in acromegalic patients.

Peverelli E

Eur J Endocrinol. 2009 Aug 11;161(5):687-94. doi: 10.1530/EJE-09-0677

The dopamine-somatostatin chimeric compound BIM-23A760 exerts antiproliferative and cytotoxic effects in human non-functioning pituitary tumors by activating ERK1/2 and p38 pathways.

Peverelli E

Cancer Lett. 2009 Jul 19;288(2):170-6. doi: 10.1016/j.canlet.2009.06.034

Role of UGT1A1 and ADH gene polymorphisms in pegvisomant-induced liver toxicity in acromegalic patients.

Filopanti M

Eur J Endocrinol. 2013 Dec 21;170(2):247-54. doi: 10.1530/EJE-13-0657

d3-Growth hormone receptor polymorphism in acromegaly: effects on metabolic phenotype.

Montefusco L

Clin Endocrinol (Oxf). 72(5):661-7. doi: 10.1111/j.1365-2265.2009.03703.x

Influence of the d3GH receptor polymorphism on the metabolic and biochemical phenotype of GH-deficient adults at baseline and during short- and long-term recombinant human GH replacement therapy.

Giavoli C

Eur J Endocrinol. 2010 Jun 30;163(3):361-8. doi: 10.1530/EJE-10-0317

Filamin A (FLNA) plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells.

Peverelli E

Endocrinology. 2014 May 14;155(8):2932-41. doi: 10.1210/en.2014-1063

Different expression of protein kinase A (PKA) regulatory subunits in normal and neoplastic thyroid tissues.

Ferrero S

Histol Histopathol. 2014 Sep 26;30(4):473-8. doi: 10.14670/HH-30.473

cAMP effects in neuroendocrine tumors: The role of Epac and PKA in cell proliferation and adhesion.

Vitali E

Exp Cell Res. 2015 Nov 14;339(2):241-51. doi: 10.1016/j.yexcr.2015.11.011

Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours.

Vitali E

Endocr Relat Cancer. 2016 Jan 5;23(3):181-90. doi: 10.1530/ERC-15-0358

Identification of human somatostatin receptor 2 domains involved in internalization and signaling in QGP-1 pancreatic neuroendocrine tumor cell line.

Cambiaghi V

Endocrine. 2016 Jul 12;56(1):146-157. doi: 10.1007/s12020-016-1026-2